Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
02/2003
02/13/2003WO2003011332A1 Methods relating to improved polyepitope vaccination strategies
02/13/2003WO2003011331A2 Materials and methods relating to improved vaccination strategies
02/13/2003WO2003011330A1 Membrane vesicles of biological fluid sampled in vivo, their preparation and use in stimulating an immune response
02/13/2003WO2003011329A2 Vaccine for prophylaxis and therapy of dermatophytosis in veterinary and human medicine
02/13/2003WO2003011317A1 Modulators of notch signalling for use in immunotherapy
02/13/2003WO2003011251A1 Pulmonary formulation
02/13/2003WO2003011223A2 Immunomodulatory compounds and methods of use thereof
02/13/2003WO2003011215A2 Method and system to determine revised dosage
02/13/2003WO2003011106A2 Internal image antibodies for optical imaging and therapy
02/13/2003WO2002100430B1 Vaccine complex for preventing or treating leishmaniases
02/13/2003WO2002096457A3 Stable liquid formulations of antibodies
02/13/2003WO2002088328A8 Method for generating highly active human dendritic cells from monocytes
02/13/2003WO2002083079A3 Aerosol compositions containing formoterol for delivery to the lungs via nebulization
02/13/2003WO2002078638A3 Morpholino imaging and therapy
02/13/2003WO2002074345B1 Immune modulation by transduced hematopoietic stem cells expressing antigens and antigen-presenting cell regulatory molecules
02/13/2003WO2002072011A3 Stabilized therapeutic and imaging agents
02/13/2003WO2002069907A3 Anti-neovasculature preparations for cancer
02/13/2003WO2002065992A3 A cell therapy method for the treatment of tumors
02/13/2003WO2002060482A3 Perylenequinones for use with immunotherapy agents
02/13/2003WO2002049667A3 Vaccine for treating nicotine addiction
02/13/2003WO2002047719A3 Survical promoting ncam binding and ncam ligand biding compounds
02/13/2003WO2002044330A3 Crystal structure of rotavirus nsp4 peptide
02/13/2003WO2002038765A9 Dna encoding bovine immunoglobulin a inducing protein and uses therefor
02/13/2003WO2002033114A3 Protein-protein interactions in neurodegenerative diseases
02/13/2003WO2002032958A3 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
02/13/2003WO2002031115A3 Nucleic acid molecules and polypeptides for immune modulation
02/13/2003WO2002026778A3 Isolated peptides which bind to hla-c molecules and uses thereof
02/13/2003WO2002018565A3 Regulation of human protein phosphatase iic-like enzyme
02/13/2003WO2002009755A3 Apo-2l receptor agonist and cpt-11 synergism
02/13/2003WO2002006515A3 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
02/13/2003WO2002000862A8 32447, a novel human acyltransferase and uses thereof
02/13/2003WO2002000702A3 Regulation of human epidermis-specific serine protease
02/13/2003WO2001092331A8 Compositions and methods for the treatment of immune related diseases
02/13/2003WO2001085763A3 Chimeric peptide immunogens their preparation and use
02/13/2003WO2001070772A3 Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of an addition salt to an acid
02/13/2003US20030032995 Thermotherapy via targeted delivery of nanoscale magnetic particles
02/13/2003US20030032791 Nucleotide sequences coding polypeptide for use in the treatment of metabolic, reproductive and eating disorders
02/13/2003US20030032790 Mammal use as model in the diagnosis, prevention and treatment of hypercholesteremia or hyperlipoproteinemia, obesity, diabetes, tumors, anorexia, hyperlipidemia, lipoprotein defects, osteoporosis, arthritis and tumors
02/13/2003US20030032787 Nucleotide sequences coding polypeptide for use in the treatment and prevention of malarial infection
02/13/2003US20030032772 Peptide for use in the diagnosis and prevention of immunological and infectious disorders
02/13/2003US20030032769 Second mammalian tankyrase
02/13/2003US20030032166 Aortic carboxypeptidase-like protein and nucleic acids encoding same
02/13/2003US20030032097 DNA encoding human vanilloid receptor VR3
02/13/2003US20030032095 Novel nucleic acid sequences encoding human semaphorin-like polypeptides
02/13/2003US20030032075 Monoclonal or recombinant antibody for use in the treatment of tumors
02/13/2003US20030032073 Method for diagnosis and therapy of Hodgkin's lymphomas
02/13/2003US20030032058 Protein-protein interactions
02/13/2003US20030032050 Methods and compositions using peptide-pulsed dendritic cells for stimulating cytotoxic T lymphocytes specific for tumor cells or virus-infected cells
02/13/2003US20030032010 Methods of populating data structures for use in evolutionary simulations
02/13/2003US20030032005 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
02/13/2003US20030031686 Exposing a source animal to an antigenic agent to elicit a T-cell mediated immune response, collecting an egg from the source that transfers cellular immunity to another animal in vivo
02/13/2003US20030031683 Selecting for a strain of bacteria having an RpoS+ phenotype, inactivating mutations which render the strain attenutated, and a recombinant gene encoding the product
02/13/2003US20030031682 Pathogens useful as vaccines for therapy and/ or prophylaxis
02/13/2003US20030031679 Immunomodulatory peptides derived from heat shock proteins and uses thereof
02/13/2003US20030031670 Diagnosis and treatment of malignant neoplasms
02/13/2003US20030031669 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system
02/13/2003US20030031668 Treatment of immune complex disease with anti-CD40L antibodies
02/13/2003US20030031667 Human monoclonal antibodies to dendritic cells
02/13/2003US20030031665 Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
02/13/2003US20030031664 For therapy of pulmonary embolism, myocardial infarction, thrombosis or stroke
02/13/2003US20030031663 Immunogenic polypeptides for inducing anti-self IgE responses
02/13/2003US20030031661 Methods of recovering chaperone proteins and complexes thereof
02/13/2003US20030031657 Stem cells and their use in transplantation
02/13/2003US20030031656 Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response
02/13/2003US20030031653 Compositions and methods for eliciting immune responses with a secretion-directed protein
02/13/2003US20030031652 Systems and methods for inducing mixed chimerism
02/13/2003US20030031627 For diagnosis and therapy
02/13/2003CA2838062A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
02/13/2003CA2808598A1 Antigenic polypeptides
02/13/2003CA2780120A1 Immunologically significant herpes simplex virus antigens and methods for using same
02/13/2003CA2494304A1 Materials and methods relating to improved vaccination strategies
02/13/2003CA2456177A1 Erythropoietin and anti-tumor necrosis factor alpha combination therapy
02/13/2003CA2456007A1 Reduction in the virulence of mycobacterium tuberculosis and protection against tuberculosis by means of phop gene inactivation
02/13/2003CA2456003A1 Regulator of calcineurin
02/13/2003CA2455856A1 Targeted polymeric delivery systems
02/13/2003CA2455598A1 Lipid constructs as therapeutic and imaging agents
02/13/2003CA2455597A1 Liposomes prepared from the extractable lipids from a mycobacterium
02/13/2003CA2455365A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
02/13/2003CA2455329A1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv
02/13/2003CA2455194A1 Vascular endothelial growth factor isoform having anti-angiogenic activity
02/13/2003CA2455154A1 Receptor, the use thereof, and mouse antibodies
02/13/2003CA2455038A1 Antigens of and antibodies to translocated molecules of microorganisms and uses thereof
02/13/2003CA2454937A1 Modulators of notch signalling for use in immunotherapy
02/13/2003CA2454066A1 Pulmonary formulation
02/13/2003CA2453939A1 Identification of specific tumor antigens by means of the selection of cdna libraries with sera
02/13/2003CA2453937A1 Antigenic polypeptides
02/13/2003CA2453831A1 Vaccine for prophylaxis and therapy of dermatophytosis in veterinary and human medicine
02/13/2003CA2453522A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines
02/12/2003EP1283268A2 Recombinant vascular endothelial cell growth factor D (VEGF-D)
02/12/2003EP1283260A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
02/12/2003EP1283217A2 Antibodies against the IL-8 receptor, and their therapeutic uses
02/12/2003EP1283059A2 Therapeutic conjugates of toxins and drugs
02/12/2003EP1283057A1 Cell proliferation inhibitors
02/12/2003EP1283053A1 Inhibitors of HER3 activity
02/12/2003EP1282718A2 Chlamydia antigens and corresponding dna fragments and uses thereof
02/12/2003EP1282711A2 COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF i EHRLICHIA INFECTION /i
02/12/2003EP1282710A2 Fish vaccine against piscirickettsia salmonis
02/12/2003EP1282706A2 Natrium-calcium exchanger protein
02/12/2003EP1282705A2 Endothelial differentiation gene 6-like g protein coupled receptor
02/12/2003EP1282703A2 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods
1 ... 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 ... 1823